Nanomedicines as cancer therapeutics: current status.
Akhter S, Ahmad I, Ahmad MZ, Ramazani F, Singh A, Rahman Z, Ahmad FJ, Storm G, Kok RJ.
Akhter S, et al. Among authors: singh a.
Curr Cancer Drug Targets. 2013 May;13(4):362-78. doi: 10.2174/1568009611313040002.
Curr Cancer Drug Targets. 2013.
PMID: 23517593
Review.